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TREATING CANCER 
IN THE NEXT CENTURY 
Juana Figueroa and her son, Rafael, share a quiet moment together at St. Louis' 
Ronald McDonald House. The Figueroas are in St. Louis from their home in Peru 
seeking treatment for Rafael. 
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8    GETTING BETTER ALL THE TIME 
A New Technology Brings Hope to Cancer Patients Through an Ancient 
Therapy Called Hyperthermia. 
12    TREATING CANCER IN THE 21ST CENTURY 
A New Treatment Planning System Promises Personalized Radiotherapy. 
16    STAYING THE COURSE 
The Prolonged Search for an Effective Radiosensitizer. 
OUT OF THE DARK 
The Search for Effective Treatment Brings a Family from Peru to Mallinckrodt 
Institute of Radiology. 
SPOT NEWS 
FYI 
31      PROFILES OF THE CHIEFS 
A manipulated image from the screen of a revolutionary treatment planning system suggests the 
speed with which radiation oncology is moving into the future. The patten's organs ^sp^ed 
Tn individual colors, and the operator can manipulate the image for the clearest view. Photograph 




When James W. Owen, 
M.D., finished his residency 
at Mallinckrodt Institute of 
Radiology five years ago, he 
left what had become a group 
of close friends to enter 
practice in Topeka, Kansas. 
St. Louis slipped into the 
past, but the memories 
created here remained 
important. 
When the five-year 
milestone arrived, Owen 
began to imagine a reunion. 
Support among his colleagues 
from 1982, '83, and '84 
proved strong, and the 
reunion was organized for 
the weekend of September 
23 to 25, 1988, complete 
Ex-residents returning for 
their reunion: (sitting) David 
DiSantis and Jill White 
Sullivan, and (standing, left 
to right) Floyd Scales, Dale 
Johnston, Bob Laakman, Jim 
McDonald, Jim Weinstein, Jerry 
VanDyke, and James Owen. 
with a scientific session on 
Saturday and a trip to a 
Cardinals' baseball game. 
Nine former residents 
were able to return to St. 
Louis for the refresher. Fac- 
ulty members R. Gilbert Jost, 
M.D., and William A. Murphy, 
Jr., M.D., sat in on the con- 
tinuing education session, 
and this year's co-chief resi- 
dent Bruce Bower, M.D., 
led a tour of Mallinckrodt's 
newest facilities to bring 




The rapidly evolving 
science of biliary lithotripsy 
—the treatment of gallstones 
noninvasively with devices 
that fragment the stones 
via shock waves—was the 
subject of a three-day inter- 
national symposium in mid- 
July. The first of its kind, 
the symposium was hosted 
by Harvard Medical School. 
Second generation 
lithotriptors, potent gallstone 
solvents, and interventional 
procedures were the focus 
of discussion. Current 
knowledge was explored in 
detail by a 20-person guest 
faculty that included 
Mallinckrodt Institute's 
Bruce L. McClennan, M.D. 
The presentation by 
McClennan, "Biliary Litho- 
tripsy: Perspectives of a 
Uroradiologist," acquainted 
prospective users of the 
technology with the physical 
basis, clinical techniques, and 
initial results of the pioneer- 
ing work with the Lithostar 
done at Mallinckrodt. 
Murphy Called 
on as MRI 
Expert 
The growing importance 
of magnetic resonance 
imaging (MRI) in the diag- 
nosis and treatment of mus- 
culoskeletal conditions and 
Mallinckrodt's role as a 
leader in the field have 
been highlighted recently 
by a call for the expertise of 
William A. Murphy, Jr., M.D., 
professor of radiology. 
On September 29, 
Murphy spoke at a confer- 
ence of pharmaceutical firm 
scientists, academicians, and 
regulatory scientists from 
the Food and Drug Adminis- 
tration (FDA) gathered for 
the first time to discuss the 
form and future of thera- 
peutic drug trials in arthri- 
tis. He detailed the methods 
by which MRI might best be 
used to test the efficacy and 
safety of new arthritis drugs 
about to enter testing. 
Two weeks later, Murphy 
addressed 40 experts gath- 
ered to develop an effective 
research strategy for diag- 
nostic radiology for the 
next three to five years. 
Held to aid the National 
Institutes of Health and the 
National Cancer Institute 
with planning, the work- 
shop presented Murphy 
with the opportunity to 
assist in setting a national 
agenda for the future of 
musculoskeletal MRI. 
Murphy addressed both 
major MRI societies as an 
invited speaker at the 1988 
annual meetings of the 
Society of Magnetic Reso- 
nance in Medicine (SMRM) 
and the Society of Magnetic 
Resonance Imaging (SMRI). 
Here, too, he discussed the 
state of the art and future 
of musculoskeletal MRI. 
He also serves as an ap- 
pointee to a three-year term 
on the Scientific Program 
Committee of the American 
Roentgen Ray Society. 
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Grant Funds        Rare Honor To 
DNA Research    Barry Siegel 
A five-year, $350,000 
grant from the National 
Cancer Institute will help 
Yvonne C. Taylor, Ph.D., 
assistant professor of can- 
cer biology in radiology, 
better understand the pre- 
cise conditions under which 
cells fail to recover from 
DNA damage produced by 
radiation. 
Taylor studies potentially 
lethal damage (PLD), a class 
of cellular damage caused 
by radiation which is nor- 
mally repaired. However, 
certain manipulations of 
post-irradiation conditions 
can cause cells to not recover 
from this damage. Although 
many agents are known 
that can alter PLD recov- 
ery, what makes this dam- 
age become lethal is not 
understood at the molecu- 
lar level. Taylor's hypothe- 
sis is that the conformation 
of chromatin (DNA plus 
associated proteins)—which 
changes throughout the cell 
cycle and when cells go 
from a dividing to a non- 
dividing state—is a deter- 
mining factor in recovery 
from PLD. 
Says Taylor, "If we can 
manipulate the appropriate 
changes in DNA, then per- 
haps we can also manipu- 
late the recovery ability of 
cells in tumors." By reduc- 
ing tumor cell recovery, the 
effects of radiotherapy 
would be enhanced. 
The special citation from 
the commissioner of the Food 
and Drug Administration 
(FDA) reads: "For excep- 
tional leadership in influ- 
encing the scientific and 
regulatory environment of 
radiopharmaceutical drug 
development, reflecting 
unselfish and enthusiastic 
commitment to the FDA." 
The recipient: Barry A. 
Siegel, M.D., director of 
Mallinckrodt's Division of 
Nuclear Medicine. 
Only a very few such 
awards are presented each 
year, granted at the com- 
missioner's discretion to 
those whose contributions 
and accomplishments he 
chooses to honor. Siegel 
says his award was "totally 
unexpected," though his 
association with the FDA 
goes back to 1972 when, as 
a resident, he visited there 
for two weeks. At that time, 
the agency had just taken 
over responsibility for 
approving all radioactive 
drugs from the Atomic 
Energy Commission. Faced 
with a large influx of new 
drug applications, the 
administration brought in a 
few outside experts to help 
review those applications. 
Siegel was one of those 
called upon. Ever since, he 
has been a consultant to 
the FDA's Division of Oncol- 
ogy and Radiopharmaceuti- 
cal Drug Products, traveling 
to Washington D.C. several 
times each year as an advi- 
sor and problem-solver. 
During his years of ser- 
vice, Siegel says his two big- 
gest contributions have been 
to oversee the development 
of guidelines for the clinical 
evaluation of radiopharma- 
ceutical drugs and to pro- 
mote a change in the method 
by which instructions and 
indications for a drug's use 
are adopted. Because of his 
influence, the FDA first 
began to consider evidence 
from the academic litera- 
ture as a basis for issuing 
guidelines regulating radio- 
pharmaceutical use. 
In his letter notifying 
Siegel of the award, FDA 
Commissioner Frank E. 
Young, M.D., Ph.D., wrote, 
"To be selected for special 
recognition should be most 
satisfying since accomplish- 
ments such as yours impact 
the well-being of the public'' 
Barry A. Siegel, M.D. 
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Residents, fellows, and 
trainees ofMallinckrodt Insti- 
tute of Radiology for 1987-1988 
were (front row) Doctors 
Jonathan Wiener, Larry D. 
Schertz, David A. Thorne, R. 
Gilbert Jost, Bruce L. Bower, 
Lynn Barrett, Ronald G. 
Evens, Gary D. Shackelford, 
Scott N. Nadel, John T. 
Engels, Amy A. Mosher, V. Marie 
Tartar, Steven S. Eilenberg, 
Barbara A. Garner, (second 
row) Doctors R. Stephen 
Surratt, Paul D. Kountz, Jr., 
Charles F. Garvin, Johnson 
Liou, Steven L. Solomon, Ted 
J. Cardoso, David N. Rabin, 
M. Alan Burns, Scott D. 
Stevens, Michael R. Schiering, 
Jonathan D. Root, David L. 
Rifken, Andre S. Strzembosz, 
Threasa H. Reiman, (third 
row) Doctors R Kim Nelson, 
John Clemett, Richard J. 
Pacini, Sonke Harms, Howard 
C. Hutt, William G. Way, Jr., 
Allan J. Romano, Michael B. 
Evert, Dale M. Fletcher, 
James S. Newman, Paul L. 
Molina, Thomas F. Hirsch, 
Thomas C. Winter III, Charles 
A. James, Kevin C. Funk, and 




When renowned radia- 
tion oncologist Malcolm A. 
Bagshaw, M.D., spoke at 
Mallinckrodt Institute of 
Radiology on June 24, the 
news he had to share was 
good. Reporting on his 
study of the world's largest 
group of prostate cancer 
patients, Bagshaw com- 
mented that in a particu- 
larly successful subgroup, 
eighty-six percent of those 
treated with radiotherapy 
had retained their sexual 
potency 15 months after 
treatment. Fifty percent 
still had erectile potency 
seven years later. Conven- 
tional surgery almost always 
results in impotency, and 
even controversial nerve- 
sparing surgery can't claim 
such success. 
Delivering the annual 
Probstein Oncology lecture, 
Bagshaw detailed his use of 
controlled radiation to treat 
more than 900 men suffering 
prostate cancer in a 30-year 
study at Stanford University, 
where he heads the medical 
center's Department of 
Radiation Oncology. 
Bagshaw recalled the 
anecdote of one of his 
patients, a man in his 80s 
with a large but localized 
carcinoma of the prostate, 
who tolerated the treatment 
without difficulty and sur- 
vived for more than 20 years 
with no further evidence of 
cancer. 
A world authority in the 
use of linear accelerators 
for the treatment of cancer, 
Bagshaw was instrumental 
in developing radiotherapy 
as a curative treatment for 
early stage prostatic cancer. 
About 90,000 new cases of 
the disease are diagnosed 
annually, and it is the sec- 
ond leading cause of cancer 
deaths in men 55 and older. 
The Probstein Oncology 
Lecture was established by 
Sally and Norman K. Prob- 
stein in honor of William 
Fair, M.D., former head of 
urology at Washington Uni- 
versity School of Medicine, 
and Carlos Perez, M.D., direc- 
tor of the Radiation Oncol- 
ogy Center at Mallinckrodt. 
Brink Named 
To Two Posts 
One of Mallinckrodt's 
chief technologists, Gary S. 
Brink, R.T., B.S., FASRT, has 
been selected to serve simul- 
taneously on two national 
committees for the American 
Society of Radiologic Tech- 
nologists (ASRT), the largest 
organization representing 
technologists. 
Brink has been named a 
member of the Resolutions 
Committee, in which position 
he will help to consider and 
format suggestions submit- 
ted from the membership at 
large. Brink is one of 12 
members of the committee 
from across the country. 
His concurrent reap- 
pointment to the Commission 
on Professional Develop- 
ment means that Brink will 
also serve to review those 
resolutions that concern 
professional development 
and, as its vice-chairman, 
help to set the agenda for 
the national organization's 
policy on that topic. 
Evens Named 
To ACR Board 
Ronald G. Evens, M.D., 
professor and head of the 
Institute, has been appointed 
to the Board of Chancellors 
of the American College of 
Radiology (ACR), "one of 
the most senior positions in 
the profession and definite- 
ly an honor," according to 
the ACR's Paul Fullagar. 
"The position is filled only 
by recognized leaders." 
The post is more than 
honorary, however, since 
the board is the governing 
body of the ACR, setting 
policy for that national 
organization on the advice 
of the elected council mem- 
bers. Traditionally, members 
of the board are reappointed 
twice, serving a total term 
of three years. A member 
may also succeed himself for 
a second three-year term. 
Concomitantly, Evens 
was named to the chairman- 
ship of the ACR's Commission 
on Technology Assessment 
and Efficacy Studies. The 
commission studies new 
treatments and technologies, 
then develops an official 
position for the ACR. In 
addition to guiding radiolo- 
gists, the information is made 
available to other medical 
MALLINCKRODT INSTITUTE OF RADIOLOGY 
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specialties to inform physi- 
cians about the efficacy and 
application of radiology's 
developing techniques. The 
commission, which Evens 
now leads, consists of at least 




After testing at 
Mallinckrodt Institute of 
Radiology since December of 
1986, the Siemens Lithostar 
received FDA pre-market 
approval as a treatment 
device for kidney stones on 
September 30. A second 
generation lithotriptor that 
requires no water bath and 
greatly reduces the need for 
anesthesia, the Lithostar is 
now officially approved for 
sale in the U.S. 
More than 500 patients 
participated in clinical 
trials here. According to co- 
chief investigator Bruce L. 
McClennan, M.D., professor 
of radiology, the Lithostar 
is destined to become an 
important machine for 
treating kidney stones. 
An investigational device 
exemption (IDE) has also 
been granted by the FDA so 
that clinical trials can begin 
using Lithostar to treat bili- 
ary duct stones. Hepatic, 
cystic, and common duct 
stones all will be treated 
with the Lithostar, employing 
the same shock generators 
used in disintegrating kidney 
stones. Shortly after Christ- 
mas, Siemens is scheduled 
to deliver a new shock gen- 
erator to be added to the 
Lithostar, making it appli- 
cable to gallstones as well. 
Setting The 
Pace 
Late in September, the 
installation of a new mag- 
netic resonance (MR) scanner 
began when the lid was lifted 
off the fifth floor and the 
magnet was lowered into 
place with a large crane. 
The new 1.0 Tesla machine 
replaces the .5 Tesla machine 
that was the first Siemens 
unit in this country. With 
much improved image quality 
and able to produce images 
much more quickly, the new 
scanner is Siemens' latest 
model. According to Chuck 
Armstrong of Siemens, the 
1.0 Tesla power level makes 
the unit capable of many 
kinds of studies, both neuro- 
logical and musculoskeletal. 
Joseph K.T. Lee, M.D., 
professor of radiology, who 
heads Mallinckrodt's MRI 
effort, says the new machine 
incorporates many changes 
in both hardware and soft- 
ware and employs a new, 
more efficient coil design. 
As this was written, he 
anticipated an eight-week 
installation and shakedown 
period, with the first 
patients expected to be 
seen shortly after Thanks- 
giving, or just about the 
time this edition of Focal 
Spot is distributed. 
Also on the fifth floor, a 
new computed tomography 
(CT) scanner is now in oper- 
ation. The Somatom Plus 
from Siemens is the first of 
its kind in this country and 
one of only two operational 
in the world. 
A developmental 
machine for which new 
algorithms and software are 
still being created, the Plus 
first scanned patients in 
mid-September. According 
to StuartS. Sagel, M.D., 
professor of radiology, the 
machine's design incorpo- 
rates a continuously rotating 
scanning ring and detector 
array. That design greatly 
reduces the interscan time 
and, along with other 
improvements, produces an 
average scan time of one 
second per slice. Such 
speed reduces problems 
related to movement, par- 
ticularly respiration by the 
patient. The scanner samples 
data almost simultaneously 
from two views, greatly 
reducing artifacts. 
The magnet for the new 
Siemens magnetic resonance 
scanner is lowered through the 
roof of the fifth floor, guided 
by many hands. 






In the opinion of the 
president of the American 
Hospital Association (AHA), 
physicians and other 
healthcare workers have a 
responsibility not only to 
provide quality treatment, 
but to serve as advocates of 
public policy that insures 
"appropriate, accessible 
care for all patients." 
Delivering the 17th 
annual Wendell G. Scott 
Lecture on September 12, 
Carol McCarthy, Ph.D., J.D., 
painted the big picture of 
the state of current health 
policy and its effect on clin- 
ical outcomes. Payment pol- 
icies in both the private 
sector and through Medicare, 
the trend toward more out- 
patient care, the medically 
indigent without insurance 
coverage, and demands for 
the measurement of care 
quality all are areas in 
which McCarthy says public 
policy is very active. 
Anticipating pressure for 
more unified payment sys- 
tems, McCarthy noted that 
more than forty percent of 
all hospitals will lose money 
Carol McCarthy, Ph.D, J.D., 
(left); Mrs. Wendell G. Scott; 
and Ronald G. Evens, M.D. 
treating Medicare patients 
this year, yet suggested that 
the government will assume 
a greater measure of long- 
term costs. The bedrock of 
the insurance system "is in 
the private sector and 
employer-based insurance. 
But that bedrock has eroded. 
Of the nation's thirty-seven 
million uninsured, fifty-three 
percent have a full-time, full- 
year link to the workplace," 
she said in detailing the 
problems she sees. "Perhaps 
it is time that all businesses 
accept the cost of health 
coverage, just as they do 
the cost of a minimum 
wage, as a societal obliga- 
tion and a cost of business,'' 
McCarthy said. She urged 
her audience not to ignore 
health policy matters in the 
interest of the technical 
aspects of medicine. 
President of the AHA 
since June of 1986, McCarthy 
previously served as presi- 
dent of the Massachusetts 
Hospital Association and in 
executive positions with 
other hospital organizations. 
She holds a law degree and 
a doctorate in healthcare 
economics. Well versed in 
healthcare administration, 
planning, and finance, she 
is also a contributing editor 
to the textbook, Health 




Michael J. Albertina, 
R.T., B. A., chief technologist 
of operations at Mallinckrodt, 
examines modern healthcare 
management techniques in 
a five-page article pub- 
lished in the June, 1988, 
edition of Administrative 
Radiology. The article 
explores administrative 
concepts that have prevailed 
in healthcare and the ways 
in which they are changing 
as the study of personnel 
management evolves. Some 
of the problems that occur 
as technology advances and 
the pressures of efficiency 
are felt are also treated. 
"Effective management," 
Albertina writes, "focuses 
on taking into account the 
human needs and aspira- 
tions of employees.'' 
Calling on the healthcare 
industry at large to accept 
more participative forms of 
management, Albertina 
says, ' 'the administrator 
must begin to function as 
team leader. He must begin 
to rely more on the knowl- 
edge, attitudes, and skills of 
others than formal authori- 
ty and control of informa- 
tion to move the hospital 





concepts, the effects of 
ionizing radiation, and cell 
population kinetics were 
the principal subjects of 
instruction during a full- 
time oncology clerkship 
program offered to first- 
year medical students by 
Mallinckrodt Institute of 
Radiology over the summer. 
Students participated in 
clinical activities or assisted 
with laboratory investiga- 
tions related to oncology. 
This year's group—D. Ross 
Dickson, Ahmed F. Ghouri, 
Evelyn C. Kase, and Robert 
C. Quackenbush—were all 
members of the first-year 
class at Washington Univer- 
sity Medical School. 
At season's end, each of 
the four gave a presenta- 
MALLINCKRODT INSTITUTE OF RADIOLOGY 
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tion summing up the 10 
weeks' work. An audience 
of technologists and physi- 
cians filled Scarpellino 
Auditorium for the talks. 
Joseph R. Simpson, M.D., 
Ph.D., associate professor 
of radiology in the Radia- 
tion Oncology Center, coor- 
dinated the program for the 
eighth year. 
New Radiation Oncology resi- 
dents and new fellows at 
Mallinckrodt are (front row, 
left to right) Doctors Farrokh 
Dehdashti, fellow in Nuclear 
Medicine; Carol Yates, fellow 
in abdominal radiology; 
Ronald G. Evens, professor 
and head of the Institute; 
Elvira Lang, fellow in inter- 
ventional radiology; Cheryl 
Sisler, fellow inpediatric 
radiology. (Back row, left to 
right) Doctors Martin Keisch, 
resident in Radiation Oncology; 
Jeff Michalski, resident in 
Radiation Oncology; Jerold 
Saef, fellow in Nuclear Medi- 
cine; Kenneth Lee, fellow in 
Nuclear Medicine; Tsuneo 
Hirano, fellow in Nuclear 
Medicine.  
Eleven physicians have been 
accepted into the Institute's 
residency program in Diagnos- 
tic Radiology. They are (front 
row, left to right) Doctors 
Andrew Landes; Edith Rang; 
Ronald G. Evens, professor 
and head of the Institute- 
Dixie J. Anderson, residency 
program coordinator; William 
Horstman; Clint Anderson, 
(back row, left to right) Doctors 
JohnEngels, chief resident; 
Jonathan White; Robert Smith; 
Ronald Robinson; Jeffrey 
Borders; Jamie Surratt; Clark 
West; Mark Mayhle; Bruce 
Bower, co-chief resident.  
FOCAL SPOT, FALL/WINTER 




ALL  THE  TIME 
By Candace O'Connor 
r \ 
Last Christmas, Forrest Becker, a 69-year-old 
retired jeweler, knew something was desper- 
ately wrong. He felt weak, he couldn't sleep, 
he had pains coursing through his legs. Then 
his doctor gave him the bad news. The colorectal cancer 
he had faced five years earlier was back, this time as 
an inoperable mass invading the sacrum, a triangular 
pelvic bone at the base of the spine. 
With a full course of chemotherapy and radiation 
behind him, Becker came to Mallinckrodt Institute of 
Radiology seeking specialized help with treatment 
complications. He needed more radiation for the tumor 
that was pressing hard against the nerves running down 
into his legs. But this time, he was only eligible for 14 
treatments-half his initial dose-since more might 
damage the very nerves that Becker needed to protect. 
How to supplement that dose and strike a more 
effective blow at his cancerous mass? This summer, 
Becker became one of the first three patients treated 
on a promising new piece of equipment now helping 
to shrink abdominal and pelvic tumors that lie deep 
within the body. This machine, the Sigma 60/BSD-2000, 
uses the latest technology to administer an ancient, 
though still experimental, form of heat treatment caUed 
hyperthermia. 
Mallinckrodt is currently 
one of six U.S. institutions 
embarking on a national 
study to track the results of BSD- 
2000 therapy Buoyed by hyper- 
thermia's success in fighting 
lesions less than four centimeters 
deep, doctors are hoping this 
new machine can produce similar 
results on deep-seated tumors, as 
much as six to 10 centimeters 
below the skin. 
"Our experience with recur- 
rent superficial tumors shows we 
have a tremendous advantage 
when we mix hyperthermia with 
radiation or chemotherapy," says 
Bahman Emami, M.D., professor 
of radiology and chief of the 
hyperthermia section, who has 
written the protocol for this 
national study. 
"In our institution, we have 
achieved sixty to seventy percent 
complete eradication," adds 
Emami. "So if we heat these 
tumors just as well as we heated 
the superficial ones, what's 
wrong with hoping we'll achieve 
the same results?" 
Only seven weeks after the 
last of his three hyperther- 
mia sessions, Forrest Becker 
is sold on the procedure. He's 
walking better and gaining weight. 
People stop him to remark how 
good he looks. Even the 50-minute 
drive from Breeze, Illinois, is well 
worth it. "I'd drive him three 
hours for this treatment "adds his 
son, A.G. Becker. 
"I haven't felt this well in a 
year," says Becker. "I tell every- 
one at Mallinckrodt that I'm the 
best ad they've got." 
Another hyperthermia unit, 
the BSD-1000 Annular Phased 
Array System, was previously used 
at Mallinckrodt in cases of inoper- 
able pelvic and abdominal malig- 
nancy. In national and institu- 
tional studies of cancer patients 
treated with this machine, the 
results were encouraging when 
the tumor was heated to 42 or 43 
degrees Celsius for at least 30 
minutes. Unfortunately, equip- 
ment limitations made this kind 
of heating difficult to achieve. 
Patient tolerance to the old 
equipment was also a problem. "In 
sixty percent of the patients we 
had local discomfort and pain. In 
twenty percent, we had problems 
with apprehension," says Emami. 
"They were anxious and wanted 
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to get out. They felt exhausted." 
At fault was the design of the 
machine, which resembled a 
large, opaque box. Patients lay 
prone on a stretcher, the heating 
unit centered over the area of 
their tumor. Unable to see in or 
out, they felt claustrophobic. 
New Technology Design 
he BSD Corporation, manu- 
facturer of the old unit, 
answered these criticisms 
in creating the BSD-2000 succes- 
sor unit. This time, they housed 
heating antennae in a much 
smaller, transparent unit which 
slides easily over the pelvic 
region and allows patient and 
doctor to see what is going on. 
Coupled to the antennae is a 
Forrest Becker: Walking better and gain- 
ing weight. 
water bag which also adds to the 
patient's comfort. At the start of 
the treatment, the bag fills with 
warm water, which cools as the 
heating progresses. 
But the major advance comes 
in the machine's vastly improved 
technology. First, it allows doc- 
tors to steer the heat directly to 
the tumor, not simply to a cross 
section of the body. Second, 
through its computer link, it 
gives doctors a chance to preplan 
the power needed in each of the 
machine's eight antennae to get 
the necessary heat to the tumor. 
These antennae work by 
radiating electromagnetic waves 
into the patient's body. This low- 
frequency radiation—even lower 
than that of a microwave oven- 
generates an electrical field 
which, in turn, creates conduc- 
tive current that heats the tissue. 
"But you need more than 
that," says Robert Myerson, M.D., 
Ph.D., assistant professor of radi- 
ology, who has been performing 
phantom research and treating 
patients using this new equip- 
ment. You can't simply dump 
power into the body; you need to 
deposit it in an organized way 
where it is needed." 
We have a tremendous 
advantage when we 
mix hyperthermia 
with radiation or 
chemotherapy. 
That's where the steering 
comes in. Unlike the earlier unit, 
this one allows doctors to adjust 
the phase and amplitude of each 
pair of antennae. ' 'Ideally, we 
would like to satisfy two require- 
ments : to cover the tumor with the 
maximum possible electric field 
and to spare normal tissue as 
much as possible," says Myerson. 
While planning their treat- 
ment strategy, doctors 
glean information from 
the patient's CT scan to deter- 
mine the target point. They also 
take measurements of the 
patient and enter data in the 
computer, together with initial 
amplitude and phase estimates. 
Using this data, the computer 
then prints out a colorful graph 
which predicts power distribu- 
tion over a cross section of the 
body. Red is the area of the most 
intense heat; blue, the least. 
Based on these predictions, doc- 
tors may revise their phase and 
amplitude estimates. 
Several factors complicate 
these estimates, Myerson says. 
The computer's predictions 
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assume that the antennae oper- 
ate independently of each other. 
In fact they interact, loaning 
power and borrowing it to and 
from each other. Doctors need to 
correct for this interaction to 
achieve the power they need. 
Accuracy may also be affected 
by such hard-to-predict factors as 
patient bloodflow. If power is 
deposited in an area with heavy 
bloodflow, the patient's body may 
dissipate some of this power, and 
a lower temperature may result. 
On the whole, though, "this 
machine does the physics about 
as well as any deep hyperthermia 
unit can do it," says Myerson. 
"We have more control over 
power deposition than we ever 
had in the past, and we have as 
much control over patient com- 
fort as we can get." 
The Treatment Session 
Taped to the patient during 
treatment are four probes 
which use the surface elec- 
tric field to measure power distri- 
bution to the tumor area. Three 
or four other probes—inserted in 
such natural openings as bladder, 
rectum, and vagina—monitor tis- 
sue temperature. Another one 
measures systemic temperature, 
while a last one is placed in the 
soft tissue near the tumor. 
In less than half an hour, 
patients reach the 42 or 43 
degree temperature and, ideally, 
should sustain it for half an hour 
or more. They are not anesthe- 
tized or medicated; in case they 
experience discomfort, they can 
quickly say so. Altogether, 
several weekly hyperthermia 
treatments are usually scheduled 
for each patient. "But I'm satis- 
fied if we can get in one success- 
ful session," says Myerson. "That 
may be enough to do the job." 
Not all cancer patients are 
eligible for hyperthermia, he cau- 
tions. A healthy heart is necessary, 
since this treatment can heat large 
blood vessels and accelerate the 
pulse rate. Currently limited to 
deep-seated pelvic and abdomi- 
nal cancer, it is not yet available 
for tumors of the thorax. 
"In our feasibility study, if 
we can show that we are able to 
deliver the necessary tempera- 
ture in fifty or sixty percent of 
the patients, we will look at 
other tumors—ones that have a 
low cure rate with conventional 
treatment modalities," says 
Emami. "Locally advanced pros- 
tate, cervix, and bladder are 
potentially all here." 
Forrest Becker is awaiting the 
results of his follow-up CT scan to 
Robert J. Myerson, M.D., assistant 
professor of radiology in the Radiation 
Oncology Center, examines hyperther- 
mia patient Forrest Becker.  
see how his tumor looks now. At 
the same time, Mallinckrodt 
doctors are studying the unit 
that treated him to determine 
how effective it is in arresting 
tumor growth. 
The bottom line is this: "We 
now have a better means of treat- 
ing tumors in the depths of the 
body," says Emami. "If this 
machine performs in the way we 
expect it to, it should be a signifi- 
cant advance." □ 




IN THE 21st CENTURY 
By Suzanne Hagan 
P A ICt ic ure this. It's the year 
2000, and you're looking across the desk at your doctor. 
Concern is in his eyes. He explains that you have lung 
cancer. Within the hour you are whisked to a CT simula- 
tor where a series of 60 to 80 images is made. Your doctor 
studies the films, analyzing every inch of you on the com- 
puter screen. The images are then fed into a computer 
programmed with your doctor's plan of therapy. In 
minutes, the computer reconstructs your torso, sculpt- 
ing a colorful picture of your body in three dimensions. 
As the picture is completed, the entire volume and area 
of your tumor are revealed, as is the volume of the nor- 
mal tissue surrounding it. Every detail of the tumor can 
be seen as your image moves around on the screen. 
As a result of this complex image processing, your 
doctor and the medical physicist assigned to your case 
can tailor a cancer treatment to the special contours and 
configurations of your anatomy. The highest possible 
dose of radiation can be delivered to the tumor in your 
lung without injury to your heart, spinal cord, and 
healthy lung tissue. The chances of controlling your 
tumor are good, and the probability of side effects from 
treatment is minimal. In 1988, such a precise three- 
dimensional treatment planning system for cancer is 
being developed at Mallinckrodt Institute. 
TREATING CANCER 
Mi 4 4 1%  IW 
anY cancers are very 
sensitive to radia- 
.tion," says Bahman 
Emami, M.D., who specializes in 
the radiation treatment of cancer 
at Mallinckrodt's Radiation 
Oncology Center. "Yet there are 
important problems we encoun- 
ter. One problem is to find the 
best way to aim the radiation so 
as not to miss the tumor and still 
spare healthy organs." 
Emami, a member of the team 
working on the treatment plan- 
ning research, describes its 
advantages: "One of my patients 
had a tumor in the chest region 
that could not be treated with a 
dose as large as I would have liked 
because the heart was in the field. 
We were forced to treat with a 
lower dose to preserve the heart. 
If the computer-driven three- 
dimensional system had been 
available, I could have used more 
scans to work out a treatment plan 
that would have taken that patient 
to the dose I wanted, still sparing 
the heart. It just bothers me." 
Currently cancer specialists 
plan radiation treatment by 
Radiation oncologists 
continue to encounter 
the problem of 
finding the best way 
to aim the radiation 
beam without 
missing the tumor 
and still sparing 
healthy tissue. 
hand, drawing the target volume 
on the CT scans and delineating 
the tumor area on the simulator- 
generated X-ray films. Lack of 
time and technology limit the 
number of CT scans that the doc- 
tor can realistically use. These 
limitations often compromise 
cancer treatment. 
W: 4 4"\    Te warvt radiation therapy delivered safely and effec- 
tively," explains Robert Morton, 
director of the Radiation Research 
''We're designing our 
systems for cancer 
specialists to use, not 
for computer 
scientists." 
Program at the National Cancer 
Institute (NCI). "As part of that 
effort, we want to know what 
dosage is delivered not only to 
the tumor, but also to normal tis- 
sue nearby." What is needed is a 
system that quickly combines the 
patient's 60 to 80 CT scans into a 
three-dimensional image and the 
software for planning and deliv- 
ering radiation therapy. 
Morton's program has funded 
six institutions in two separate 
contracts—Memorial Sloan- 
Kettering, Massachusetts General 
Hospital, M.D. Anderson Hospital, 
University of Michigan, Univer- 
sity of Pennsylvania, and Mallin- 
ckrodt Institute—to evaluate the 
potential of three-dimensional 
radiation treatment planning for 
several hard-to-treat cancers. 
James A. Purdy, Ph.D., a 
radiation physicist, is the princi- 
pal investigator of the two NCI 
contracts at Mallinckrodt Institute. 
His group used an image processor 
developed at Washington Univer- 
sity's Biomedical Computer Labo- 
ratory for molecular biology. It 
was adapted to accept multiple 
images from CT scans, displaying 
these images on a video screen. 
The treatment planning software 
combines these "slices," sculp- 
ting them into a lifelike three- 
dimensional image. The video 
screen also displays a simulation 
of the radiation beam impinging 
on the treatment area. When the 
viewer uses the workstation's joy- 
stick, the images can be turned 
so that any aspect is visible. 
Thus, a physician can accurately 
simulate the effects of a planned 
pathway of radiation. Such preci- 
sion has never before been used 
in planning radiation therapy. 
Oi 4 4 f~\ ne thing I particularly } liked about the St. Louis group's approach," says 
Morton, "is the ability to visualize 
the enhancement of the field of 
treatment. Their system enables 
a viewer to see the field edges 
encompassing the tumor and plan 
a beam trajectory that avoids as 
much of the normal tissue as possi- 
ble. I think that of all the contracts, 
theirs was the best approach." 
"We are developing new tools 
for radiation treatment," explains 
Purdy. "These new tools will bet- 
ter represent the three-dimen- 
sionality of the tumor. The X-ray 
and radiation beam therapy used 
for treatment will better conform 
to the tumor's volume. This will 
enable us to use higher doses of 
radiation to treat the tumor and 
control cancers that we previ- 
ously could not." 
Purdy and his co-workers, who 
presented their 3-D work at the 
American Society for Therapeutic 
Radiology and Oncology (ASTRO) 
meeting in October, emphasize 
that without the data provided 
by CT scans, such an approach to 
radiation treatment planning and 
delivery would not be possible. 
However, since the software is 
only now becoming available for 
combining the images into a 
graphic representation of the 
patient's anatomy and for provid- 
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ing real time interactivity, a can- 
cer specialist like Emami must do 
his treatment planning by hand. 
That is, he uses at most two or 
three CT scans, MR images, or 
standard X-ray images to hand 
draw the desired treatment area 
where the beam is to be directed. 
Then he uses a conventional treat- 
ment planning system to compute 
the overall dosage theoretically 
delivered, typically ignoring tissue 
density effects. This estimated 
dosage doesn't take into account 
the radiation scattering effects 
from inhomogeneities within the 
treatment area. Nor is there 
extensive data to determine the 
tolerance of normal tissue to 
radiation. Radiation oncologists 
have to use their experience to 
decide where and how much to 
irradiate a patient to kill as much 
of the tumor as possible. 
The system that Purdy's 
group is developing will get 
around these difficulties. All 
the diagnostic images, not just 
two or three, can be used by the 
computer to construct an elec- 
tronic sculpture of the patient's 
anatomy, allowing the doctor a 
timely way of delineating the 
tumor. The computer can calcu- 
late the amount of radiation 
striking any point within the 
tumor volume, taking into 
account the scattering effects 
from inhomogeneities. Thus, the 
total dosage being delivered can 
be figured accurately. 
Radiation oncologists realize 
that their efforts to plan doses, 
even with three-dimensional plan- 
ning, will need new technology 
to verify the treatment if the 
potential is to be realized. Cur- 
rently, a weekly X-ray image made 
during the course of a patient's 
radiotherapy is compared with one 
made prior to treatment to decide 
if the radiation beam needs to be 
adjusted. Ideally, verification 
should take place as radiation is 
being delivered, not afterward. 
John Wong, Ph.D., a member 
of Purdy's group, has taken on 
this problem. He has developed a 
system of plastic fiber optics to 
measure radiation passing through 
the patient to a fluorescent screen 
below. The fiberoptic cables pick 
The images produced by the new system 
show the body's features in realistic 
detail, revealing for study the volume of 
the tumor to be treated.   
up the image from the fluorescent 
screen and transmit it to a TV 
camera interfaced with a com- 
puter workstation. The transmit- 
ted image shows whether the 
radiation is reaching the desired 
area and displays any fluctua- 
tions in the beam due to setup 
variations and patient motion. 
Purdy and his research team 
also hope to develop com- 
puter programs to control 
the radiation beam's direction and 
shape, customizing it to allow for 
a patient's individual contours and 
irregularities. "Rather than treat- 
ing only rectangular or square 
fields," says Purdy, "we will be 
able to shape the field. We will 
also be able, under computer 
control, to move the patient and 
the beams simultaneously, allow- 
ing us to deliver a much higher 
dose to the patient." 
Purdy's goal is to develop all 
the necessary software to make 
these computer innovations a 
reality, and to do it in such a way 
that dedicated workstations are 
networked together into a 3-D 
radiation therapy system. Even- 
tually, supercomputers will be 
available for such applications, 
but Purdy's system will definitely 
be user friendly: "We're design- 
ing our systems for cancer 
specialists to use, not computer 
scientists,'' he says. 
Emami is enthusiastic about 
the potential of this new system, 
which should be available for 
limited clinical use in about three 
years: "Right now, if I give a cer- 
tain patient a particular dose, I 
might expect a cure rate of thirty- 
five percent. But if I can increase 
this dose to twice as much—an 
"One of my 
patients had a 
tumor in the chest 
region that could not 
be treated with as 
high a dose as 
I would have liked 
because the heart 
was in the field. 
We were forced to 
treat with a lower 
dose to preserve 
the heart" 
option I don't have now because 
of the limits of the normal tissue 
to radiation exposure—then I can 
expect a much improved cure 
rate." By the year 2000, doctors 
hope to be able to offer their 
cancer patients a cure rate of 
fifty percent. □ 
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The Prolonged Search 
for an Effective Radiosensitizer 
by Steve Kohler 
cientific research doesn't often proceed as 
smoothly as its practitioners would like. The big 
breakthrough announced in the headlines is the 
rare exception; more often, tiny advances are preceed- 
ed by years of diligence. As an endeavor, research re- 
quires not just insight and precision, but optimism and 
hope. 
When Tbdd Wasserman, M.D., needs inspiration to 
stay the course in his own work, he thinks back to a 
childhood experience. At the age of six, he participated 
in the clinical trials of the Salk polio vaccine, receiving 
three doses of either placebo or active vaccine—at the 
time he didn't know which. After many failed attempts 
to control polio, the eventual success of those trials 
resulted in what Wasserman calls "one of the most 
important changes in medicine to occur during my pre- 
professional lifetime." Then, in an uncharacteristically 
personal note, he adds, "It inspired me." 
Tbdd H. Wasserman, M.D., and his 
patient, Thomas Consiglio, in consulta- 
tion. Consiglio was apart of the phase I 
clinical trials ofSR-2508 and is a vocal 
advocate of the drug's promise.  
STAYING THE COURSE 
These days, Wasserman, pro- 
fessor of radiation oncology 
in Mallinckrodt's Radiation 
Oncology Center and chief of the 
Department of Radiation Oncol- 
ogy at Jewish Hospital, is on the 
convoluted trail of improved 
treatments for cancer—a more 
complicated disease than polio. 
Actually, Wasserman points out, 
cancer is a whole family of dis- 
eases that will always require a 
variety of cures and treatments. 
Specifically, his work entails 
the testing of drugs that will make 
cancer cells more vulnerable to the 
effects of radiation. Radiation 
destroys cells by inducing certain 
chemical changes from which they 
cannot recover. If those changes 
can be enhanced via chemical 
manipulation, then radiation's 
effects can be magnified. 
For 30 years it's been known 
that many tumors are organized 
The potential for 
good is at least as 
great as it was in the 
case of polio and the 
Salk vaccine. 
as concentric rings of cells, each 
layer identifiable according to its 
oxygen content. At the core is 
often a dead region, isolated from 
both blood supply and oxygen. 
At the surface lie active, highly 
oxygenated cells that radiation 
kills without difficulty. Between 
those two is a zone of oxygen- 
poor, or hypoxic, cells that radia- 
tion has difficulty affecting. In a 
state akin to dormancy, these 
cells can quickly become revital- 
ized and dangerous again should 
the overlying cells be stripped 
away, as they are during a course 
of radiation therapy. 
Research in the lab has 
shown that oxygenating the 
hypoxic region of tumors 
makes those cells more suscepti- 
ble to treatment with radiation. 
Effectively treating hypoxic cells 
may require three times the radi- 
ation dosage necessary for treat- 
ment in an oxygen-rich setting. 
That dose of radiation can be too 
much for surrounding normal 
tissue to bear. Early attempts to 
increase the efficiency of radiation 
therapy by increasing oxygen 
levels included placing patients 
in hyperbaric chambers to force 
oxygen deep into their systems. 
Cumbersome and impractical, 
that approach was abandoned. 
But Wasserman and his col- 
leagues recognized that chemical 
agents might be able to sensitize 
hypoxic cells to radiation, reach 
In the laboratory where SR-2508 is 
assayed, Todd H. Wasserman, M.D., 
holds a vial of the radiosensitizer he's 
worked with for more than five years. 
into the dormant zones of tumors, 
and yet not sensitize normal tis- 
sue. In 1977, clinical trials began 
to test the drug misonidazole, 
commonly called miso, as a 
tumor-cell sensitizer. 
A sort of "fool's gold" in Was- 
serman's explanation, miso does 
not actually increase the oxygen 
level of hypoxic cells, but it 
' 'induces chemical events after 
radiation similar to those of oxy- 
gen." And it shows a preference 
for hypoxic tissues, collecting there 
via a mechanism that remains 
not totally understood. Appar- 
ently, the drug makes it impossi- 
ble for damage done to the cells' 
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DNA by radiation to be repaired. 
The effected cell dies. 
The problem with miso came 
during the translation from the 
laboratory to the practical world 
of treating patients. The drug 
could not be tolerated in doses 
Wasserman eooplains: 
"Good science doesn't 
always end in 
positive results." 
large enough for its effectiveness 
to be measured or relied upon. 
Therapeutic gain was never 
demonstrated; research had not 
run smoothly at all. 
But the theory continued to 
make sense and offer promise. A 
derivative of miso—known as 
etanidazole or SR-2508-works in 
much the same way. Except that 
it can be administered in total 
doses three times as large as miso 
thanks to its lower toxicity. Still 
present is the predictable side 
effect of a cumulative neuropathy, 
a tingling sensation particularly 
in the extremities that builds after 
several doses have been adminis- 
tered. But the serious mental 
confusion that limited the effec- 
tiveness of miso is gone. Thank- 
fully, the neuropathy disappears 
after the regimen is completed. 
According to Norman 
Coleman, M.D., chairman 
of the Radiation Therapy 
Department at Harvard Medical 
School, SR-2508 is the first drug 
good enough to really test the 
hypothesis that cell sensitizers 
can increase the efficiency of 
radiation therapy in cancer. He 
says, "It's true that we have not 
succeeded. But we have a much 
better drug now." 
Wasserman, eager for success 
after 14 years of leading the 
research, agrees. He says, "We 
would not have developed 
SR-2508 if miso had been an 
immediate success. And this is 
probably not the last drug we 
will have to develop. But it may 
let us know that we have the 
right approach." 
Not that the work to date has 
no value. As Wasserman explains, 
"Good science doesn't always end 
in positive results. Understandable, 
repeatable results, yes. But not 
always and every time positive. If 
you know more when you're done, 
if you answer a question, then it 
can be considered successful." 
Testing in phase III clinical 
trials, in which large numbers of 
patients are treated with radiation 
and with or without SR-2508, 
The serious mental 
confusion that limited 
the effectiveness of 
miso is gone. 
began in July, 1987, at 25 North 
American institutions, all mem- 
bers of the Radiation Therapy 
Oncology Group (RTOG). Twenty- 
five European cancer centers are 
testing SR-2508 simultaneously 
in a parallel study. Head and 
neck tumors, readily quantifia- 
ble, are under study and results 
are expected in 1990, just in time 
for the Seventh International 
Conference on Chemical Modi- 
fiers which Wasserman will chair. 
He was co-chairman for the sixth 
conference held earlier this year 
in Paris. 
Organizing the research and 
bringing investigators 
together from around the 
world to share their insight has 
required extraordinary perse- 
verance. Many negative and null 
trials have had to be reported. 
Fully half of Wasserman's academic 
life has been devoted to the 
struggle to bring cell sensitizers 
like SR-2508 to their potential. The 
results of the trials now being 
conducted will be the watershed. 
But no matter what those 
results are, this research could 
hardly have had a more dedicated 
captain. From his office at Har- 
vard, Coleman says Wasserman 
has been "the engine that has 
run it. The research might have 
died several times if it hadn't been 
for Todd Wasserman. He gets peo- 
ple together; he's skilled in deal- 
ing with the National Institutes 
of Health, a source of grant money, 
and a tremendous facilitator." 
Carlos Perez, M.D., director of 
the Division of Radiation Oncol- 
ogy at Mallinckrodt, joins in reg- 
istering his hope for the work. 
"The biological basis is very 
sound. It works well in the lab. 
Even if we don't hit a home run 
here, we will still win the game 
with small, incremental gains." 
The potential for good is at 
least as great as it was in the case 
Cancer is a whole 
family of diseases 
that will always 
require a variety of 
cures and treatments 
of polio and the Salk vaccine. So 
Todd Wasserman moves along at 
the rate that good science will 
allow, suffering the frustration of 
small victories. He develops and 
tests new compounds in blind 
trials much like the one he was 
involved in 36 years ago when he 
received the Salk vaccine that 
later erased the menance of polio 
for so many. □ 
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darkness of his St. Louis room. 
Xeroderma pigmentosum, a rare skin 
disease, restricts his exposure to light. 
by Steve Kohler 
W1 J 
herever she goes in St. Louis, 
Juana Figueroa takes along 
two companions. One is her 
son, Rafael, whose rare disease has brought the pair here from 
their home in Lima, Peru. The other is a small, stout notebook, 
its pages listing the names of all those people who have helped 
the mother and son on their quest to find treatment for Rafael. 
The entries in the book are in chronological order—the most 
recent contacts last. At the top of page one is the name of Carlos 
A. Perez, M.D. When Mrs. Figueroa and her son got off the plane 
from Lima, the only English they knew was the name of Perez 
and that of Mallinckrodt Institute of Radiology. 
They'd flown for almost 10 hours, courtesy of Eastern Air- 
lines, in the hope that Perez, who directs the Radiation Oncol- 
ogy Center at Mallinckrodt, could provide the extraordinary care 
that Rafael requires. Diagnosed at age four as suffering from 
xeroderma pigmentosum (a rare pigmentary disease of the skin 
that leaves its victims extra-sensitive to the damage wrought 
by ultraviolet light), Rafael had seen his condition worsen; eight 
years later Lima's specialists could be of little help. More 
advanced therapy was required. 
Mayer Zaharia, M.D., chief of the Department of Radiation 
Therapy at Lima's Institute of Neoplastic Diseases, a huge cancer 
hospital, suggested Mallinckrodt Institute. Zaharia had been a 
visiting professor here and had seen the successes of Perez and 
his colleagues. 
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OUT OF THE DARK 
Deplaning on July 7, the 
Figueroas—mother and son 
—found their way to South 
Kingshighway and eventually to 
Pat Norton, whose name is entered 
second in the little notebook. A 
clinical research assistant in 
Radiation Oncology with a degree 
in Spanish, Norton immediately 
assumed the role of mentor to 
the visitors. She arranged lodging 
and acted as a translator while 
Juana's English came back from 
her days as a high-school student 
of the language. 
Specialists were called in. The 
name of Ann Martin, M.D., was 
inscribed indelibly when she took 
over management of the derma- 
tological aspects of Rafael's case. 
Otolaryngologists Gershon Spector, 
M.D., and Donald Sessions, M.D., 
joined the team when biopsies 
revealed that the underlying 
xeroderma pigmentosum had led 
to a melanoma on Rafael's ear 
that required surgery. 
Written large in the book is 
the name of Karen Forsman, M.D., 
a resident in dermatology who has 
acted to coordinate the therapy 
and all the contributing specialists. 
Among those whose expertise 
she has called upon is Fred Chu, 
M.D., a Medical School ophthal- 
mologist managing Rafael's eye 
problems. George Hruza, M.D., a 
cutaneous surgeon, treated skin 
cancer on Rafael's face. 
Anyone granted a look into 
Juana's book would also find the 
name of Rafael's roommate and 
friend, a youngster who shared 
25 days with Rafael in Barnard 
Free Skin and Cancer Hospital. 
Despite a language barrier, the 
two delighted together in the 
humor of the drawings in the 
"Calvin and Hobbes" comic strip. 
As Rafael's condition began to 
respond to the collaborative 
efforts of Washington Univer- 
sity's best, he was again able to 
laugh at the escapades of the boy 
and his imaginary pet tiger. 
Carlos A. Perez, M.D., director of the 
Radiation Oncology Center and lead 
physician in Rafael's treatment that 
includes many Washington University 
Medical School experts. 
Diagnosed at age 
four, Rafael had seen 
his condition 
worsen; eight years 
later Lima's 
specialists could be 
of little help. 
Strictly a night person as a result 
of his aversion to light, Rafael 
occasionally awakened his 
mother with his laughing. But 
she was delighted to have her 
sleep disturbed by a sound she 
had heard too little of lately. 
Juana's list continued to grow: 
Mike, a nurse on Barnard's fourth 
floor; the good people of a church 
who welcomed the Figueroas 
into their congregation; a local 
Peruvian family whose members 
helped with understanding North 
American customs. And always 
the doctors who assessed and 
treated and explained. 
4 4FTlne doors opened," 
Juana says in a tone that 
-L conveys both gratitude 
and awe. "Good things just keep 
happening; we keep going." She is 
certain that she and her son were 
destined to find Mallinckrodt. 
Despite the poor long-term prog- 
nosis for Rafael, she says they feel 
encouraged by his recent progress. 
For her, it's a miracle that Rafael 
sometimes beams out a smile from 
beneath the brim of his tradition- 
al Peruvian farmer's sombrero. 
Perez is pleased, but not par- 
ticularly surprised, at the success 
he and his colleagues are having. 
' 'We have a top national center 
here, with the very best people 
in many fields. Our reputation is 
spreading beyond the Midwest.'' In 
addition to Rafael, Perez recently 
has treated four other patients 
from outside the country, including 
a cabinet member from Uruguay. 
Referrals come from the many 
physicians who visit here as fellows 
or guest lecturers and from the 
contacts made by the Mallinckrodt 
staff members on their own 
travels. "They find out that we 
do first-rate work," Perez says. 
On Rafael's twelfth birthday, 
he was honored at three 
separate birthday parties. 
He spoke to his father, his sisters, 
aunts, and cousins in Peru, and 
the family shared a few happy 
moments together. 
On that day, too, the family 
began to lay plans to relocate to 
St. Louis where they have found 
so much help. Difficulties in 
immigrating don't worry Juana; 
she has encountered greater 
hurdles. 
She takes life in small pieces 
and says, "That was a good day. 
There are good days and bad 
days, but living this way we are 
nearer to God. Every day is 
thanks to Him. And we learn this 
lesson: Have faith. God will do 
the rest for you." 
That said, it's clear that 
Juana Figueroa's constant com- 
panions number three, not just 
two. In addition to the tangible— 
her son and the book of names- 
there is also an abiding faith that 
generates bright hope. D 
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Jeffrey J. Brown, M.D., 
assistant professor of radi- 
ology, Division of Diagnos- 
tic Radiology 
Donald E. Gayou, Ph.D., 
research associate in three- 
dimensional imaging, Divi- 
sion of Diagnostic Radiology 
Landis K. Griffeth, M.D., 
Ph.D., assistant professor 
of radiology, Division of 
Nuclear Medicine (completed 
a 4-year residency in Diag- 
nostic Radiology and Nuclear 
Medicine at Mallinckrodt 
Institute of Radiology) 
Marshall E. Hicks, M.D., 
assistant professor of radi- 
ology, Division of Diagnos- 
tic Radiology 
Peter P. Lai, M.D., Ph.D., 
assistant professor of radi- 
ology, Division of Radiation 
Oncology 
Francisco Li-Aravena, 
M.S., research assistant in 
radiation physics, Division 
of Radiation Oncology 
Frederick A. Mann, M.D., 
assistant professor of 
radiology, musculoskeletal 
section, Division of Diag- 
nostic Radiology 
Victor A. Marcial-Vega, 
M.D., instructor in radiology, 
Division of Radiation 
Oncology 
PaulL. Molina, M.D., 
instructor in radiology, 
Division of Diagnostic Radi- 
ology (completed a 1-year 
fellowship in chest radiol- 
ogy at Mallinckrodt Insti- 
tute of Radiology) 
William H. Perman, Ph.D., 
assistant professor of radia- 
tion sciences in radiology, 
Division of Radiation 
Sciences 
Thomas K. Pilgram, Ph.D., 
research associate in three- 
dimensional imaging, Divi- 
sion of Diagnostic Radiology 
Ying Su, B.S., research 
assistant in radiation phys- 
ics, Division of Radiation 
Oncology 
OFF STAFF 
Lynn Barrett, M.D., co-chief 
resident 1987-1988, com- 
pleted a 4-year residency in 
Diagnostic Radiology and has 
accepted a fellowship at Rush 
Presbyterian, St. Luke's Medi- 
cal Center, Chicago. 
Inta S. Berzins, M.D., com- 
pleted a 4-year residency in 
Diagnostic Radiology, and 
one year of training in 
Nuclear Medicine and has 
accepted a position as staff 
radiologist at Parkland 
Hospital-Southwestern 
Medical Center, University 
of Texas, Dallas. 
Scott J. J. Evans, M.D., 
completed a 4-year residency 
in Diagnostic Radiology and 
has received an imaging fel- 
lowship at San Francisco 
General Hospital. 
Joseph N. Fields III, M.D., 
assistant professor of radi- 
ology, Division of Radiation 
Oncology, hasjoined the staff 
of the Department of Radia- 
tion Oncology, Memorial 
Medical Center, Springfield, 
Illinois. 
Kevin C. Funk, M.D., com- 
pleted a 4-year residency in 
Diagnostic Radiology and 
has entered private prac- 
tice at Eastern Idaho 
Regional Medical Center, 
Idaho Falls. 
Charles F. Garvin, M.D., 
instructor in radiology, 
completed a 2-year fellow- 
ship in neuroradiology and 
has entered private prac- 
tice at St. Luke's Hospital, 
St. Louis. 
James R. Geurin, M.D., 
completed a 4-year 
residency in Radiation 
Oncology which included 
one year as an American 
Cancer Society Clinical Fel- 
low and has entered private 
practice with Radiation 
Oncologists, Inc., Kansas 
City, Kansas. 
David C. Hardy, M.D., 
assistant professor of radi- 
ology, Division of Diagnos- 
tic Radiology, has entered 
private practice in mam- 
mography and abdominal 
and skeletal imaging at LDS 
Hospital, Salt Lake City. 
Howard C. Hutt, M.D., 
instructor in radiology, 
completed a 1-year fellow- 
ship in neuroradiology. 
Scott N. Nadel, M.D., chief 
resident in radiology 
1987-88, completed a 
4-year residency in Diag- 
nostic Radiology and has 
entered private practice in 
Bradenton, Florida. 
David N. Rabin, M.D., 
instructor in radiology, 
completed a 1-year fellowship 
in abdominal radiology and 
has accepted a position as 
attending radiologist in 
imaging at Rush Presbyteri- 
an, St. Luke's Medical 
Center, Chicago. 
Threasa A.H. Reiman, 
M.D., instructor in radiology, 
completed a 4-year residen- 
cy in Diagnostic Radiology 
and a 1-year abdominal 
radiology fellowship, and 
has entered private prac- 
tice with Valley Radiologists 
Ltd., Phoenix. 
David L. Rifkin, M.D., 
assistant in radiology, has 
completed seventeen months 
of training in the Division 
of Nuclear Medicine and 
has entered private prac- 
tice in Northhampton, 
Massachusetts. 
DebraD. Rosenthal, M.D., 
completed a 4-year 
residency in Diagnostic 
Radiology, and one year of 
training in Nuclear Medi- 
cine and pediatrics, and has 
entered private practice at 
St. John's Mercy Medical 
Center, St. Louis. 
Thomas E. St. Amour, M.D., 
completed a 4-year residen- 
cy in Diagnostic Radiology 
and has entered private 
practice with Radiology 
Associates, Little Rock, 
Arkansas. 
Vythialingam 
Sathiaseelan, Ph.D., assis- 
tant professor of radiation 
physics in radiology, Division 
of Radiation Oncology, has 
entered private practice at 
Northwestern Memorial 
Hospital, Chicago. 
David H. Schmidt, M.D., 
completed a 4-year residen- 
cy in Diagnostic Radiology 
and has received an imag- 
ing fellowship at the 
University of California, 
San Diego. 
Clement C. Wen, M.D., 
instructor in radiology, 
completed a 2-year fellow- 
ship in neuroradiology and 
has entered private prac- 
tice in Baton Rouge. 
Xingren Ying, Ph.D., 
research associate in radia- 
tion physics, Division of 
Radiation Oncology, has 
accepted a position at the 
Institute of Automation, 
Chinese Academy Sciences, 
Beying, People's Republic 
of China. 
Frederick R. Zivnuska, 
M.D., instructor in clinical 
radiology, has entered pri- 
vate practice in radiation 
oncology at St. Luke's 
Hospital, Milwaukee. 








Jeffrey L. Borders, M.D., 
Ph.D., graduated from Cal 
Tech with a Bachelor of 
Science degree in biology. 
Borders received his Ph.D. 
in bioengineering and his 
medical degree from the 
University of California, 
San Diego. 
Edith H. Rang, M.D., 
graduated from Brown 
University with a Bachelor 
of Arts degree in human 
biology and received her 
medical degree from the 
University of Pennsylvania. 
She is a member of AOA. 
Andrew B. Landes, M.D., 
graduated from Wesleyan 
University with a Bachelor 
of Arts degree in chemistry 
and completed his medical 
education at Washington 
University School of 
Medicine. 
Mark May hie, M.D., 
graduated from Seattle 
Pacific University with a 
Bachelor of Science degree 
in engineering science. 
Mayhle received his Master 
of Science degree in chemi- 
cal engineering and his 
medical degree from the 
University of Washington. 
He is a member of AOA. 
Ronald O. Robison, M.D., 
received a Bachelor of Sci- 
ence degree in biology and 
general science from Oregon 
State University and com- 
pleted his medical education 
at the Oregon Health Sci- 
ences University. Robison is 
a member of AOA. 
Robert M. Smith II, M.D., 
Ph.D., graduated from 
Florida State University with 
a Bachelor of Science degree 
in physics and a Ph.D. in 
molecular biophysics. He 
received his medical degree 
from Emory University. 
Jonathan C. White, M.D., 
Ph.D., received a Bachelor 
of Science degree in physics 
and math from MIT. White 
received his Master of Sci- 
ence degree and Ph.D. in 
physics as well as his medi- 
cal degree from Stanford 
University. 
NEW FELLOWS 
KarenS. Baker, M.D., 
instructor in radiology, is a 
fellow in musculoskeletal 
radiology. She received a 
Bachelor of Science degree 
in biology and her medical 
degree from the University of 
Kentucky. Baker completed 
her diagnostic radiology resi- 
dency at the Medical Col- 
lege of Virginia, Richmond. 
Elvira V. Lang, M.D., 
instructor in radiology, is a 
fellow in interventional 
radiology. Lang received her 
medical degree, completed 
her residency in radiology, 
and was a faculty radiologist 
at the School of Medicine, 
University of Heidelberg, 
West Germany. In the United 
States, Lang completed a 
radiology internship and a 
fellowship in angiography 
as well as a residency at the 
University of California, 
San Diego. 
Cheryl L. Sisler, M.D., 
instructor in radiology, is a 
fellow in pediatric radiology. 
She received a Bachelor of 
Science degree in pharma- 
cology at the University of 
Wisconsin-Madison and com- 
pleted her medical educa- 
tion at St. Louis University. 
Sisler completed her resi- 
dency in diagnostic radiol- 
ogy at Jewish Hospital. She 
is a member of AOA. 
Carol K. T&tes, M.D., 
instructor in radiology, is a 
fellow in abdominal radiol- 
ogy. She received her medi- 
cal education at University 
of Oklahoma Health Sciences 
Center and completed her 
residency in diagnostic 
radiology at Baptist Medical 
Center, Oklahoma City. She 
is a member of AOA. 
FIRST YEAR 
RESIDENTS 
Clinton M. Anderson, M.D., 
received his Bachelor of 
Arts degree in biology from 
the University of Tennessee. 
He completed his medical 
education and internship at 
Vanderbilt University, 
Nashville. Anderson is a 
member of AOA. 
William G. Horstman, M.D., 
received his Bachelor of 
Science degree in chemistry 
from the University of South 
Dakota. A 1983 graduate of 
Washington University 
School of Medicine, 
Horstman completed his 
internship and two years of 
residency in urology at the 
Naval Hospital in San Diego. 
Jamie T. Surratt, M.D., 
received a Bachelor of Sci- 
ence degree in physical thera- 
py from the University of 
Kentucky. She completed 
her medical education at 
the University of Louisville, 
Kentucky, and completed 
her internship and a 1-year 
residency in internal medi- 
cine at Barnes Hospital. 
Surratt is a member of AOA. 
O. Clark West, M.D., com 
pleted his premedical train- 
ing at Drake University. A 
1986 graduate of Washing- 
ton University School of 
Medicine, West completed 
his internship and a 1-year 
residency in internal medi- 
cine at Barnes Hospital. He 
is a member of AOA. 
Kris J. Van Lorn, M.D., 
graduated from the Univer- 
sity of Oregon with a Bach- 
elor of Arts in biology and 
received his medical degree 
from the Oregon Health Sci- 
ences University School of 
Medicine. He completed his 
internship at Mercy Hospi- 
tal, San Diego, and a 3-year 
diagnostic radiology resi- 
dency at University of 
California, San Diego. He is 
a member of AOA. 
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Avraham Eisbruch, M.D., 
received his medical degree 
and completed his internal 
medicine residency at Tel- 
Aviv University, Israel. He 
completed a fellowship in 
medical oncology at Uni- 
versity of Texas and in 
oncology and radiation 
therapy at Tel-Aviv 
University. 
Martin Keisch, M.D., 
received his Bachelor of 
Science degree in biology 
from State University of 
New York at Stony Brook 
and his medical degree 
from Tufts University, 
Boston, Massachusetts. 
Keisch completed his 
internship at the Boston VA 
Medical Center and is a 
member of AOA. 
Jeff M. Michalski, M.D., 
received his premedical 
training at the University of 
Wisconsin and completed 
his medical education at 
the Medical College of 
Wisconsin. He completed 
his internship and one year 
of residency in radiation 
oncology at Columbia- 
Presbyterian Medical 





Shahrokh, M.D., received 
her medical degree from 
Pahlavi Medical School, 
Shiraz, Iran, had an intern- 
ship and three years of 
radiology residency in Iran, 
and completed a 2-year res- 
idency in nuclear medicine 
at the Medical College of 
Wisconsin Hospitals. 
Tsuneo Hirano, M.D., 
received his medical training 
at the Gunma University 
School of Medicine, Japan, 
and completed his radiol- 
ogy residency at Tulane 
University Medical Center 
Hospital, New Orleans. 
Kenneth J. Lee, M.D., 
received his B.S. and M.B. 
degrees in medicine and 
surgery from the University 
of Melbourne, Australia. He 
received the Fellow degree 
in internal medicine and 
cardiology from the Royal 
Australasian College of 
Physicians. 
JeroldL. Saef, M.D., 
received his Bachelor of Arts 
degree in chemistry from 
Florida Atlantic University 
and his medical degree from 
the University of South 
Florida College of Medicine. 
He completed a 2-year 
residency in cardiology and 
a 3-year residency in internal 
medicine at St. Elizabeth's 
Hospital of Boston, an 
affiliate of Tufts University 
School of Medicine. Saef 
has received U.S. Board 
certification in internal 
medicine. 
VISITING PROFESSORS 
& INVITED LECTURERS 
James P. Crane, M.D., pro- 
fessor of radiology, pre- 
sented Meet-the-Professor 
Session on "The Fetus with 
a Problem" at the AM Insti- 
tute of Ultrasound in Medi- 
cine—World Federation for 
Ultrasound in Medicine 
Annual Meeting, Washing- 
ton, D.C., October 17-21. 
Crane was visiting profes- 
sor at Harvard Medical 
School, September 30— 
October 2, where he spoke 
on "Prenatal Diagnosis and 
Management of Genitouri- 
nary Malformations" and 
"Sonographic Diagnosis of 
Neural Tube Defects." 
Bahman Emami, M.D., 
professor of radiology, pre- 
sented "Clinical Experience 
with Interstitial Hyperther- 
mia and Radiation Therapy" 
at the Role of Hyperthermia 
in Radiation Oncology- 
Cooperative Meeting 
between the United States 
and the People's Republic of 
China, Beijing, China, 
September 8-10. 
Mokhtar Gado, M.D., pro- 
fessor of radiology, presented 
"MR—Anatomy of the Spine 
and Cord at the Craniocer- 
vical Junction" at the XVth 
Congress of the European 
Society of Neuroradiology 
in Wurzburg, Germany, Sep- 
tember 13-17. Gado pre- 
sented "Overall Approach 
to Low Back Pain," "Princi- 
ples of Interpretation of MR 
Images of the Brain," and 
"Lesions of the Sellar 
Region" at the 1988 Harvard 
Postgraduate Course, "Cur- 
rent Concepts in Neuroradiol- 
ogy, Head and Neck Radiolo- 
gy, and Neuro-MRI," in 
Boston, October 3-7. 
Louis A. Gilula, M.D., pro- 
fessor of radiology, attended 
the National Podiatric Asso- 
ciation, Anaheim, August 19. 
Gilula lectured on "Muscu- 
loskeletal Neoplasia" and 
' Arthrography/Tenography 
of Foot and Ankle." He 
attended the American 
Society for Surgery of the 
Hand, Baltimore, Septem- 
ber 15. He participated in a 
panel discussion on "Imag- 
ing Techniques." Gilula 
attended the International 
Skeletal Society, Sydney, 
Australia, September 25— 
October 10, where he spoke 
on "Wrist Arthrography— 
Update." He spoke on "CT 
and 3-D CT of the Wrist," 
"Analytic Approach to Car- 
pal Injuries," "CT of the 
Foot and Ankle" at Diag- 
nostic Radiology Update, 
University of Texas, South- 
western Medical Center, 
Dallas, October 28-30. 
Gilula was co-organizer of 
an international "Wrist 
Investigator Workshop," 
and lectured on "The Wrist- 
1988," "Radiographic Anat- 
omy and Exam," "Inflam- 
mation X-Ray Exam," and he 
attended a panel on' 'Clinical 
Evaluation of the Wrist," 
Tampa, November 3-5. 
Jay P. Heiken, M.D., asso- 
ciate professor of radiology, 
presented "MRI of the 
Pelvis" at seminars in Mag- 
netic Resonance Imaging in 
Door County, Egg Harbor, 
Wisconsin, July 29-31. 




& INVITED LECTURERS 
Andrei Laszlo, Ph.D., assis- 
tant professor of cancer 
biology in radiology, lectured 
on "Mechanisms of Ther- 
motolerance: Less Damage 
or Better Repair" at Stan- 
ford University, Depart- 
ment of Radiology, June 29; 
Laboratory of Cell Biology, 
Lawrence Berkeley Labora- 
tory, July 5; Radiation 
Oncology Research Labora- 
tory, Department of Radiol- 
ogy, University of California, 
San Francisco, July 8. Laszlo 
was visiting staff scientist 
at the Radiation Biology 
Section of the Radiation 
Oncology Branch of the 
National Cancer Institute, 
July 24—August 2. He visited 
Beaumont Hospital and 
Wayne State University in 
Detroit and the University 
of Michigan at Ann Arbor, 
November 8—10, where he 
presented a series of lectures 
"On the Molecular Mecha- 
nisms of Thermotolerance." 
Joseph K.T. Lee, M.D., 
professor of radiology, 
chaired a scientific session 
at the 7th annual scientific 
meeting of the Society of 
Magnetic Resonance in 
Medicine, San Francisco, 
August 20-26. Lee spoke at 
a seminar on "Magnetic 
Resonance Imaging of the 
Liver and Male and Female 
Pelvis" in Los Angeles, 
September 16-18. 
Bruce L. McClennan, M.D., 
professor of radiology, 
attended the Uroradiology 
'88 conference at the Uni- 
versity of Minnesota PGC, 
Minneapolis, where he pre- 
sented "Low Osmolar Con- 
trast Media" and "Oncologic 
Imaging." McClennan was 
an invited speaker at the 
Royal Australian College of 
Radiology (RACR), Auckland, 
New Zealand, October 2-7. 
He also attended uroradiol- 
ogy meetings in Melbourne, 
Australia, October 14-16, 
where he was a guest lec- 
turer. McClennan presented 
"Low Osmolar Media—U.S. 
Experience," "CTof the 
Indeterminate or Problem 
Mass," "Prostatic Ultra- 
sound," and "Lithotripsy— 
Beyond the Stone Age." 
Tom R. Miller, M.D., Ph.D., 
associate professor of radi- 
ology, presented a paper 
' 'Three-Dimensional Display 
of SPECT Images" at the 
annual meeting of the Mis- 
souri Valley Chapter, Soci- 
ety of Nuclear Medicine, 
Des Moines, September 17. 
Stephen Moerlein, Ph.D., 
assistant professor of radia- 
tion chemistry in radiology, 
presented "Recent Devel- 
opments in Radiopharma- 
ceuticals for PET and 
SPECT" at the Nuclear 
Research Center, Juelich, 
Federal Republic of Germany, 
on July 12. 
William A. Murphy, M.D., 
professor of radiology, spoke 
as the invited education 
session lecturer on "MRI of 
Bone Marrow" at the mid- 
February meeting in Boston 
of the Society for Magnetic 
Resonance Imaging. Murphy 
also was invited plenary 
session speaker at the 
Meeting of the Society of 
Magnetic Resonance in 
Medicine in San Francisco, 
August 20-26. The topic 
was "MRI of the Bone Mar- 
row and Musculoskeletal 
Tumors." He was an invited 
speaker at a conference titled 
"Early Decisions in DMARD 
Development" jointly 
planned and co-sponsored by 
the Arthritis Foundation, 
the American Rheumatism 
Association, the National 
Institutes of Health and the 
Federal Drug Administration 
in Washington, D.C, Sep- 
tember 29. The topic was 
"Newer Imaging Techniques 
in Proving Efficacy of Can- 
didate Compounds." Murphy 
was an invited participant at 
a workshop on "Directions in 
Research in Diagnostic Imag- 
ing" held by the National 
Cancer Institute, Winston- 
Salem, North Carolina, 
October 12-14. He was an 
invited lecturer at continuing 
education meetings on Prac- 
tical Magnetic Resonance 
Imaging 1988, Las Vegas, 
October 21-22, where he 
spoke on "MRI of Musculo- 
skeletal Tumors," "MRI of 
the Bone Marrow: Basic 
Concepts," "MRI of the Bone 
Marrow: Clinical Aspects." 
He also spoke at the 17th 
Annual Seminar Musculo- 
skeletal Disorders, Phoenix, 
November 11-13, on"MRI of 
Bone Marrow," "MRI of 
Musculoskeletal Tumors," 
and "Forensic Radiology." 
Henry D. Royal, M.D., 
associate professor of radi- 
ology, attended Management 
of Radiation Accidents, 
Albuquerque, October 6-8, 
where he presented "Car- 
cinogenesis and Radiation," 
"Bone Marrow Transplanta- 
tion" and "Combined Injury." 
StuartS. Sagel, M.D., 
professor of radiology, was 
a visiting professor at 
St. Luke's/Presbyterian Hos- 
pital, Rush Medical School, 
Chicago, July 15. 
Barry A. Siegel, M.D., 
professor of radiology, served 
on the faculty of the eleventh 
annual postgraduate course 
on Practical Radiology, Uni- 
versity of Virginia School of 
Medicine, Charlottesville, 
Virginia, October 10-13, 
where he presented lectures 
on "Ventilation-Perfusion 
Scintigraphy and Pulmonary 
Embolism" and "Gastrointes- 
tinal Bleeding Scintigraphy." 
Joseph R. Simpson, M.D., 
Ph.D., associate professor 
of radiology, spoke on 
"Techniques and Results of 
Interstitial Implants in 
Malignant High Grade Gli- 
omas" at Tufts University, 
New England Medical Cen- 
ter Hospitals, May 20. 
Jerold Wallis, M.D., assis- 
tant professor of radiology, 
attended Clinical Nuclear 
Medicine Update, sponsored 
by the Missouri Valley Chap- 
ter of the Society of Nuclear 
Medicine, Des Moines, 
September 17, where he 
presented "Selection of 
Optimal SPECT Reconstruc- 
tion Filters." 
Todd H. Wasserman, M.D., 
professor of radiology, 
attended the semiannual 
Cancer and Acute Leukemia 
Group B Meeting in Atlanta, 
October 26, where he 
participated in the lym- 
phoma, radiation, and lung 
subcommittee. 
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Bahman Emami, M.D., 
professor of radiology, 
attended the 5th Symposium 
on Hyperthermic Oncology, 
Kyoto, Japan, September 
4-15. Emami presented 
"Interstitial Hyperthermia 
and Brachytheraphy in the 
Treatment of Head and Neck 
Cancer," "Thermoradio- 
therapy of Malignant Mela- 
noma," and "Regional 
Hyperthermia in the Treat- 
ment of Recurrent Deep- 
Seated Tumors: Analysis of 
Phase I Trial." He attended 
the first annual Oncology 
Symposium: Non-Small Cell 
Lung Cancer, Kansas City, 
November 18, where he 
presented "Radiotherapeutic 
Management of Non-Small 
Cell Lung Cancer." 
Andrei Laszlo, Ph.D., 
assistant professor of cancer 
biology in radiology, attended 
the 5th International Sym- 
posium on Hyperthermic 
Oncology, Kyoto, Japan, 
August 29—September 3. 
He presented a poster titled 
"Mechanisms of Thermotol- 
erance: Less Damage or 
Better Repair?" and a paper 
on ' 'Modifications of Various 
States of Thermotolerance" 
in the workshop on "Modi- 
fication of Thermotoler- 
ance" and a paper on 
"Mammalian Heat Shock 
Proteins: The Search for 
Functions." Laszlo was also 
invited to speak at a satel- 
lite meeting on "Heat 
Shock Proteins" at Kyoto 
University, September 5, 
where he presented a talk 
entitled "Mammalian Heat 
Shock Proteins." 
Stuart S. Sagel, M.D., pro- 
fessor of radiology, presented 
"CT of the Mediastinum'' and 
"CT of the Pleura" at the 
Ninth Annual Brown Uni- 
versity Symposium on Diag- 
nostic Imaging, Newport, 
Rhode Island, August 8-11. 
Gilbert H. Nussbaum, 
Ph.D., associate professor 
of radiation physics in radi- 
ology, attended the 5th 
International Symposium 
on Hyperthermic Oncology 
in Kyoto, Japan, August 29— 
September 3. At this meeting 
he organized and co-chaired 
a symposium session, 
"Techniques for Electro- 
magnetic Heating," and 
presented a paper titled 
"Targeted Deep Heating 
through Manipulation of 
SAR Distributions." He also 
attended the U.S./China 
Cooperative Meeting on 
"The Role of Hyperthermia 
in Radiation Oncology," 
Beijing, People's Republic of 
China, September 8-10, 
where he co-chaired the 
opening session on "Hyper- 
thermia Physics, Engineer- 
ing, and Thermometry," and 
presented a paper titled 
"Directed Deep Heating." 
Joseph L. Roti Roti, Ph.D., 
professor of cancer biology in 
radiology, chaired two ses- 
sions at the 5th International 
Symposium on Hyperthermic 
Oncology, Kyoto, Japan, 
August 27-September 3. The 
subject of the first session 
was "Heat Induced Changes 
in Nuclear and Nuclear- 
Matrix Protein" co-authored 
with Andrei Laszlo, Ph.D., 
and the second session was 
"The Effects of Hyperther- 
mia on DNA Damage and 
Its Repair." Roti Roti 
presented a paper entitled 
"Heat-Induced Changes in 
the Protein Content of Nuclei 
and Nucleoids as Modified 
in Thermotolerant Cells by 
Procaine, Ethanol or Glyce- 
rol" co-authored with 
Nazan Turkel. 
Jeffrey J. Brown, M.D., 
assistant professor of radi- 
ology, presented "History of 
MRI" at a symposium titled 
"Application of High Tech- 
nology to Medical Care" at 
the University of California 
School of Medicine, San 
Diego, September 13. 
Judy M. Destouet, M.D., 
associate professor of radi- 
ology, presented "Mammog- 
raphy and the Augmented 
Breast" at the Third 
Annual Plastic Surgery of 
the Breast Symposium, 
Santa Fe, September 7. 
Carlos A. Perez, M.D., 
professor of radiology and 
director of the Division of 
Radiation Oncology, spoke on 
"Controversies in the Role 
of Radiation Therapy in the 
Management of Cervical 
Metastatic Lymph Nodes in 
Tumor of the Oral Cavity, 
Oropharynx and Larynx" 
at the Second International 
Conference on Head and 
Neck Cancer, July 31— 
August 5, Boston. Perez 
attended the 5th Interna- 
tional Symposium on Hyper- 
thermic Oncology, Kyoto, 
Japan, August 29—Septem- 
ber 3, where he spoke on 
"Prognostic Factors in the 
Combined Treatment of 
Tumors Radiation Dose and 
Fractionation," "Irradiation 
and Hyperthermia in the 
Treatment of Recurrent 
Carcinoma of the Breast in 
the Chest Wall," "MIR and 
RTOG Experience," and 
"Irradiation and External 
Hyperthermia in Treatment 
of Head and Neck Cancer." 
He also spoke on "Hyper- 
thermia in the Treatment of 
Cancer," "Cancer of the 
Lung," "New Techniques of 
Irradiation," and "Radiation 
Therapy in Head and Neck 
Cancer," Medellin, Colombia, 
at the 10th Anniversary 
Instituto de Ciencias de la 






The following Mallin- 
ckrodt Institute staff mem- 
bers participated in the 
30th Annual Scientific 
Meeting of the American 
Society for Therapeutic 
Radiology and Oncology, 
New Orleans, October 9-14. 
SCIENTIFIC 
SESSIONS 
Bahman Emami, M.D., 
organized and moderated 
"Photon Three-Dimensional 
Treatment Planning." He 
also presented "Three 
Dimensional Treatment 
Planning for Lung Cancer" 
and "3-D Planning in 
Thoracic Oncology!' 
James A. Purdy, Ph.D., 
organized and moderated 
"Electron Beam Dosime- 
try." He also presented 
"The Use of Dose Surfaces 
for Three-Dimensional 
Treatment Planning'.' 
John W. Wong, Ph.D., pre- 
sented "On-Line Radiother- 
apy Imaging with an Array 
of Fiber-Optic Image 
Reducers" and "Patient 
Dose Estimation Using 
Entrance and Portal Dose 
Distributions!' 
Joseph R. Simpson, M.D., 
Ph.D., moderated "Radia- 
tion Therapy Oncology Group 
(RTOG) Survival Data on 
Anaplastic Astrocytomas of 
the Brain: Does a More 
Aggressive Form of Treat- 
ment Adversely Impact Sur- 
vival?" He also presented 
"Three-Dimensional Treat- 
ment Planning Considera- 
tions for Prostate Cancer!' 
Todd H. Wasserman, M.D., 
moderated "Biology of 
Sensitize rs!' 




MartinS. Weinhous, Ph.D., 
presented "On a More Effi- 
cacious Presentation of the 




James A. Purdy, Ph.D., 




Bahman Emami, M.D., 
"Applied Techniques and 
Clinical Practice of Intersti- 
tial Hyperthermia" and 
"Three-Dimensional Treat- 
ment Planning for Lung 
Cancer" 
HONORS/   APPOINTMENTS/ 
AWARDS   ELECTIONS 
James P. Crane, M.D., 
professor of radiology, was 
named recipient of the 
Virginia Lang Chair in 
Obstetrics and Gynecology, 
August 8. 
Andrei Laszlo, Ph.D., 
assistant professor of radi- 
ology in cancer biology, 
attended the 5th Interna- 
tional Symposium on 
Hyperthermia Oncology in 
Kyoto, Japan, as one of 
seven recipients of the Out- 
standing Young Investiga- 
tors in Hyperthermia award 
sponsored by the Yamamoto 
Vinyter Company of Japan. 
Barry A. Siegel, M.D., 
professor of radiology, 
received a grant from the 
Edward Mallinckrodt, Jr. 
Foundation to research cor- 
onary artery disease using 
Positron Emmission Tomog- 
raphy. Coinvestigators are 
Mark A. Mintun, M.D., 
assistant professor of radi- 
ology, and Robert J. Gropler, 
M.D., instructor in radiology. 
Andrei Laszlo, Ph.D., 
assistant professor of cancer 
biology in radiology, was 
appointed a representative 
for the program committee of 
the 1989 national meeting of 
the North American Hyper- 
thermia Group in Seattle. 
Bruce McClennan, M.D., 
professor of radiology, was 
invited to join the ACR Inter- 
society Committee on Sys- 
tematized Refresher Courses 
as co-chairman of the Sub- 
committee on Genitourinary 
Radiology. The subcommittee 
will develop plans for a geni- 
tourinary radiology course 
for the 1989 meeting in 
New Orleans of the Ameri- 
can Roentgen Ray Society 
and future refresher courses 
in genitourinary radiology. 
TomR. Miller, M.D., Ph.D., 
associate professor of radi- 
ology, was elected president- 
elect of the Computer and 
Instrumentation Council, 
Society of Nuclear Medicine. 
TECHNOLOGIST NEWS 
Norman L. Hente, R.T., B.S., 
FASRT, was conference 
coordinator and Murray 
Lecturer for the 56th 
Annual Conference of the 
Missouri Society of Radio- 
logic Technologists. 
William A. Murphy, Jr., 
M.D., professor of radiology, 
was appointed to a three- 
year term on the Scientific 
Program Committee of the 
American Roentgen Ray 
Society. Murphy is also cur- 
rently serving on the Scien- 
tific Program Committee of 
the Radiological Society of 
North America as chairman 
of the Skeletal Committee. 
Gilbert H. Nussbaum, 
Ph.D., associate professor 
of radiation physics in radi- 
ology, was a member of the 
thesis examination commit- 
tee for S.G. Kim of the 
Department of Chemistry, for 
his dissertation on "A deute- 
rium nuclear magnetic res- 
onance spectroscopic inves- 
tigation of tumor blood 
flow in-vivo" August 18. 
ALUMNI 
NEWS 
Norbert J. Liebsch, M.D., 
Ph.D., has accepted a staff 
position in Therapeutic Radi- 
ology working on the Proton 
Beam Project at Massachu- 
setts General Hospital. 
After completion of his res- 
idency in Diagnostic Radiol- 
ogy at the Institute, Liebsch 
finished his training in 
Therapeutic Radiology at 
the Mayo Clinic. He received 
certifications in Diagnostic 
Radiology and Therapeutic 
Radiology by the American 
Board of Radiology and is cur- 
rently applying for his Massa- 
chusetts medical license. 
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CIC 
NEWS 
The Cancer Information 
Center (CIC) is cosponsored 
by the Mallinckrodt Insti- 
tute of Radiology and the 
Barnard Free Skin and 




Mr. and Mrs. Herbert R. 
Bilgram in memory of Alma 
Arnold 
Power and Grounding 
Department of AT&T in 
memory of Caladonia Roberts 
Mrs. Marilyn Busch in mem- 
ory of Adolph Sherman 
Mr. & Mrs. Donald Speraneo 
in memory of Elsie Ferguson 
Mr. Edwin B. Beissner, Jr. in 
memory of A. Wessel 
Shapleigh 
Dr. Gerald La Marsh in 
memory of Connie Foley 
Mr. & Mrs. Roy E. Lenox in 
memory of Connie Foley 
Mr. & Mrs. Roy E. Lenox in 
memory of Rudy 
Schnurbusch 
Mr. & Mrs. Frederick 
Hermann in memory of Nan 
Jones 
Social Services NW & 
Adolescent Psych Unit in 
memory of Noel Miller 
Mr. & Mrs. R. B. Thomas in 
memory of Dr. Robert 
McKibbon 
U.S. Army AVSCOM in 
memory of Lewis Jones 
Daniel P. Schrage in memo- 
ry of Dr. Lewis L. Feaster 
Anthony M. Corgiat in 
memory of Dr. Lewis L. 
Feaster 
Miss Shirley Germaine in 
memory of Mrs. Barbara 
Buford 
Sylvia Schacter in memory 
of Louis Kootman 
FYI 
Van H. Hale in memory of 
Connie Foley 
Mr. & Mrs. G.E. Ingram in 
memory of Connie Foley 
Peggy Layman & family, 
Denise Rodamich, Jean 
Stoner, Sandra Reed in 
memory of Darryl Matlock 
Mr. & Mrs. Adrian O. Levin 
in memory of Tony Halinski 
Helen M. Carter in memory 
of Janice Sue Beeler 
Emilie A. Beeler in memory 
of Janice Sue Beeler 
Mr. & Mrs. Sidney Bronfin 
in memory of Barbara L. 
Wegmann 
Mr. & Mrs. Sanford J. 
Kornbery in memory of 
Connie Foley 
Mr. & Mrs. H.J. Wakeling in 
memory of Connie Foley 
Mr. & Mrs. Clede Slade and 
Joan in memory of Mike Karr 
Mr. & Mrs. Paul A. Comer in 
memory of Morty Bibb 
Julia F. and John Yarbrough 
for Mrs. Dexter Farnsworth 
and Dexter Farnsworth 
Mrs. L.G. Kellerman in 
memory of Connie Foley 
Mr. & Mrs. Anthony DeBasio 
in memory of Calvin Owens 
Mrs. Karen C. Bizzell 
Dr. Deborah C. Love in 
memory of Connie Foley 
Mrs. Ward M. Miller, Jr. in 
memory of Connie Foley 
Nicoline F Mix in memory 
of Connie Foley 
Mr. & Mrs. Charles Stoops in 
memory of Connie Foley 
Kutis Bowling League, Red 
Bird Lanes in memory of 
James Illert 
Ms. Mary F. Saf ron in mem- 
ory of Dorothy Schwartzman 
Mrs. Dora D. Thompson in 
memory of Bene B. Hinsman 
Staff of 5400, Barnes 
Hospital Plaza in memory 
of brother of Carmeletta 
Calhoun 
"Tucker's Place", Kathy, 
Cindy, Rhonda, Gloria and 
Jerry in memory of 
Dr. Joseph Jaudon 
Marie Brettschneider 
Judy C. Hunt in memory of 
Lester Whited 
Mr. & Mrs. Sidney J. Bronzin 
in memory of Lenore S. Rosen 
Sandy Wood in appreciation 
of the thoughtfulness of 
Susie Yawitz 
Mr. & Mrs. William J. 
Kristen, Jr. in memory of 
Preston Harrison and 
Patricia Parker 
Sylvia Schacter in honor of 
wedding anniversary of Mr. 
& Mrs. George Lamb 
Daniel Miller-for the family 
and friends of Susan Miller 
Gennari in memory of 
Susan Miller Gennari 
Judy C. Hunt in memory of 
Lester Whited 
Lloyd Jacobs 
Mrs. Dorothy Showman in 
memory of Jarold E. 
McFarland 
Mr. & Mrs. Everett Siegel in 
memory of Kenneth Lever 
The Lab of 5509 Wohl 
Hospital in memory of 
Fannie Barker 
Mrs. J.E. Kellogg in memory 
of Connie Foley 
Mrs. FA. Hone in memory 
of Connie Foley 
Susan M. Huch in memory 
of Connie Foley 
Aleta Kyle in memory of 
Mark Woods 
Dorothy Weiss in memory 
of Mark Woods 
Victor and Jean Arnold in 
memory of Mark Woods 
T Gaynor Blake in memory 
of John Hillmeyer 
Helen R. Taylor in memory 
of Joseph B. Batha 
Mr. & Mrs. Carl Mounce in 
memory of Lena LaFiore 
Mr. & Mrs. Walter Werner in 
memory of William Scheper 
Donna Freeman 
KSDK donation in tribute 
of Dr. Judy Destouet 
Mr. & Mrs. James Garland- 
donation 
Helen R. Sproull in memory 
of Beau Peters 
Miriam M. Rand in memory 
of Beau Peters 
Crystal S. Heifner in 
memory of Beau Peters 
Ida Speranes in memory of 
W.C. Morris 
Mr. & Mrs. Sidney Bronfin 
in memory of Sylvia Rosen 
Mr. & Mrs. Wilbert Beshore 
in memory of Mike Niznik 
Mr. & Mrs. Richard Pelot in 
memory of Mrs. Nancy Hall 
Opal and Sharon Alles in 
memory of Dave Brumlet 
Mrs. A. J. MacDonald in 
memory of Georgia Lewis 
Mr. & Mrs. Merle J. Anker in 
memory of Max Kleiman 
Mr. & Mrs. Frederick 
Hermann in memory of 
Mary Bowman Peters 
SLDDTC, OT & PT Staff and 
Services in memory of 
Joseph Garavaglia 
Mr. & Mrs. R.J. Collins in 
memory of George Skinner 
Verna Ruzicka in memory 
of Leonard J. Mandeville 
Debbie Schachter and family 
in memory of Matthew 
Mueller 
Debbie Schachter and family 
in memory of Ann Roy 
Erma Jean Bullerdick in 
memory of Mr. Aylward 
Sylvia Schacter in memory 
of Mary Jones 
Mr. & Mrs. R.F Collins in 
memory of Beau Peters 




December 12, 1988 
City-Wide Radiology 
Conference 
MRI in the Clinical Manage- 
ment of Lymphoma 
Elias A. Zerhouni, M.D. 
professor of radiology 
Johns Hopkins Medical 
Center, Baltimore 
Scarpellino Auditorium 
January 9, 1989 
City-Wide Radiology 
Conference 
St. Louis University 
To Be Announced 
February 13, 1989 
City-Wide Radiology 
Conference 
"MRI of the Pelvis: Staging 
and Monitoring Response 
Time in Therapy" 
Herbert H. Kressel, M.D., 
professor of radiology 




March 13, 1989 
City-Wide Radiology 
Conference 
3rd Annual Daniel R. Biello 
Memorial Lecture 
"Issues Facing the Diffusion 
of Medical Technology" 
Barbara J. McNeil, M.D., 
professor, radiology & 
clinical epidemiology 
Harvard Medical School, 
Boston 
Scarpellino Auditorium 
April 10, 1989 
City-Wide Radiology 
Conference 
Leroy Sante Lecture 
St. Louis University 
To Be Announced 
May 8, 1989 
City-Wide Radiology 
Conference 
"Stereotactic Breast Biopsy' 
Judy M. Destouet, M.D., 
associate professor of 
radiology 




The BBC's Sir David 
Attenborough recently 
traveled to Mallinckrodt Insti- 
tute with a full crew to film a 
program concerning the 
modern study of fossils. Here, 
Sir David confers with 
Michael W. Vannier, M.D., 
associate professor of radiol- 
ogy and director of the image 
processing laboratory. 
Washington University Medi- 
cal School's Glenn Conroy, 
Ph.D., points out a detail on 
the CRT for the camera. 
Also visiting Mallinckrodt 
this fall was world-famous 
still photographer Alexander 
Tsiaras. Working for LIFE 
Magazine and a consortium of 
foreign publications, Tsiaras 
trained his eye on the manner 
in which radiology is aiding 
craniofacial reconstructions 
andpediatric heart surgery. 
Here, he focuses on an infant 
5 in a CT scanner's bore. 
MALLINCKRODT INSTITUTE OF RADIOLOGY 
SPOTLIGHT 
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JOHN ENGELS 
John Engels, M.D., has come 
to know precisely what he 
wants. His technique has been 
to experiment and then rule out 
that which he does not like. Now 
chief resident in Diagnostic Radi- 
ology at Mallinckrodt Institute of 
Radiology and liking it, Engels 
describes the process he's been 
through as "constantly redefin- 
ing what is personally and 
professionally satisfying." 
Reassessing his directions 
hasn't always been easy, but 
Engels has been decisive and 
unwilling to settle for less than 
the best. The son of a Chicago 
psychiatrist, he earned an under- 
graduate degree in science edu- 
caton at the University of Illinois, 
Champaign-Urbana, after the 
"hubbub" of medical school put 
him off initially. And he taught 
science on the north side of 
Chicago for a year before he real- 
ized that the unstable work envi- 
ronment for teachers in the late 
'70s, with enrollments down, 
meant an employment insecurity 
he could not tolerate. 
So Engels worked for a year 
as a research technician in cellu- 
lar immunology, then moved on 
to graduate school in the same 
field. Eventually, his testing of 
the prevailing circumstances led 
to the realization that complete 
professional satisfaction lay only 
in a career as a physician. 
Chicago's Rush Medical Col- 
lege proved fulfilling, and Engels 
followed with an internship in 
internal medicine at Washington 
University, coming here first in 
1984. From that experience, he 
learned that the peculiar demands 
of 24-hour-a-day patient care 
were not for him. "The abstract 
is more my style," Engels says, 
though he still gets plenty of 
patient interaction. 
For a time, he thought about 
following his father into psychia- 
try, but radiology kept beckon- 
ing. Although he says he's not 
"particularly oriented toward 
the technology," he's still confi- 
dent of his choice of a career in 
radiology. The greatest reward 
has been to "know the diseases, 
what causes them, and how to 
recognize them." The challenge 
of correlating what the films 
show with a patient's history and 
symptoms clearly pleases Engels. 
He'll continue to explore that 
challenge when he completes his 
residency in 1989, then enters 
private practice with a group of 
Mallinckrodt alumni at St. Louis' 
Missouri Baptist Hospital. "It's a 
general practice; we'll see it all," 
he says with anticipation. 
John Engels has known for a 
long time that he was headed into 
private practice. That decision, 
along with those that came before 
it and those being pondered today, 
was made only after he tested 
the waters. When he didn't like 
something, he looked for another 
answer. Imagining a more appro- 
priate mindset for a diagnostic 
radiologist is difficult. D 
BRUCE BOWER 
The conventional path to the 
practice of radiology- 
through college, medical 
school, internship, and residency 
—may have become more the 
exception than the rule. Witness 
Bruce Bower, M.D., new co-chief 
resident in Diagnostic Radiology 
His medical education began with 
an early commitment to a six-year 
program through which he earned 
both B.S. and M.D. degrees. 
Bower is not sure what the B.S. is 
in. "It was the M.D. I was after," 
he says with characteristic 
pragmatism. 
Bower's education has also 
continued longer than most, 
including a three-year residency 
in internal medicine and four 
years as a resident in radiology. 
His plans call for an additional 
year to be devoted to a fellow- 
ship in interventional radiology 
with Daniel Picus, M.D., here at 
Mallinckrodt before he calls his 
formal education complete. 
Though Bower knew early that 
his professional life would be 
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spent in some type of service to 
others, it was an event late in 
high school that set his course 
into medicine. Over the summer 
months, Bower and some friends 
worked at painting houses, and a 
member of the crew was involved 
in a serious motorcycle accident 
on his way home from work one 
day. Bower visited that friend 
during his convalescence and 
recognized in the medical profes- 
sion the opportunity to combine 
many of his interests. As an 
aside, he notes that the accident 
victim is also a physician today, 
just back in this country after 
three years of service as a mis- 
sionary in Africa. 
During medical training at 
Hahnemann University in Phila- 
delphia and his internal medicine 
residency at Case Western Reserve, 
Bower discovered that he was 
' 'always interested in the new 
things going on in the basement." 
New CT technology, the emergence 
of MRI, and the development of 
interventional techniques lured 
him away from internal medi- 
cine. Interventional radiology 
suits him especially well because, 
"I get restless reading films all 
day. I like to work with my 
hands, do procedures, and inter- 
act directly with patients." 
Away from the many hours 
he gives to the work each week, 
a high level of activity remains 
characteristic of Bower, who is 
single. He works out and plays 
racquetball, tennis, and touch 
football. He also contributes to 
Mallinckrodt's Softball team, for 
which he often pitches. "Unless 
Ron (Evens) shows up. Then he's 
the pitcher. Unless he says I'm 
the pitcher." 
When his residency and the 
fellowship to follow end, Bower 
foresees private practice, "prob- 
ably in Colorado, but maybe back 
in Pittsburgh." His mildly uncon- 
ventional path to his goal has not 
cost him any of his pragmatism. 
"I'll try to get the best job in the 
nicest area I can," he says. □ 
RICHARD LOVETT 
Richard Lovett, M.D., paid 
his way through the Uni- 
versity of Vermont by work- 
ing in the fire department of his 
hometown, answering the fire 
alarm. Now that Lovett is the new 
assistant chief resident in Radiation 
Oncology at Mallinckrodt, he has 
traded the fire bell for a beeper, 
but he's still on call. 
Lovett doesn't mind. He 
answers the beeper's signal many 
times during the course of a day 
that usually runs to 15 hours, 
sometimes more now that he's 
studying for boards. For Lovett, 
it's all satisfying; "everything I 
hoped for," he says. 
Life as a physician always 
appealed to him, but "the road 
looked very long" when he first 
entered college. Anxious to get out 
on his own, Lovett undertook a 
two-year course of study that 
earned an Associate's Degree as a 
nuclear medicine technologist. He 
spent the next three years pursuing 
that career at New England 
Deaconess Hospital in Boston. 
"But there are only so many 
career paths open to a technolo- 
gist," Lovett says. He knew he 
wanted to continue working with 
patients, so he went to medical 
school. The same interest in tech- 
nology that had drawn him to 
nuclear medicine made radiology 
a natural choice as a specialty. 
And a rotation in oncology in 
Vermont demonstrated just how 
he could blend his love for 
physics and the scientific with 
his desire to care for patients. 
Many of Lovett's patients are 
very ill, some of them terminally 
so. "That's sometimes difficult," 
he admits. "When you treat some- 
one for weeks on end, you develop 
an attachment. But no matter 
what the outcome, you're doing 
your best to either cure them or at 
least make them more comfort- 
able." Lovett reduces the issue to 
its basics and explains, ' 'They 
need something from me. I help." 
He is the first in his family to 
leave Vermont in the pursuit of 
his profession. Two sisters remain 
within 20 miles of the family home, 
and a brother followed a family 
tradition and became a firefighter 
with the Rutland department. 
The move to Missouri has been a 
step into a more conservative 
realm—politically and socially— 
but not an unpleasant experience 
for Lovett who says he has 
"found a niche." 
All of his work has been in 
academic departments, and Lovett 
anticipates that when he leaves 
Mallinckrodt after next year as 
chief resident, he will continue 
to mix research, writing, and 
clinical work. Exactly where, 
though, he's not sure. "I have no 
idea where I'll go," he says. 
Wherever it is, he'll remain on call 
in the service of his patients. □ 
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When magnetic resonance imaging (MRI) focuses on one "slice" of the anatomy, 
it actually makes three images. Diagnosticians study all three, comparing 
them to what they know to be normal. Lately, in Mallinckrodt's image process- 
ing laboratory, each of the three has been assigned a color, and then they've 
been combined. According to neuroradiologist Mokhtar Gado, M.D., the colori- 
zation makes the components distinct and suggests ways in which tissues are 
either similar or different. "This is just the beginning, though," Gado says. 
"We still have many questions." Here, the process has been applied to MRI 
images ofapatient's spinal cord, brain stem, and cerebellum. Note that sub- 
cutaneous fat and bone appear similar in color. Gado says that result is due to 
the presence of high fat content marrow within the bone.  
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